Elevated Expression of MALAT1 Contributes to the Survival of Drug-Tolerant Persister Cells Following Targeted Therapy in Lung Adenocarcinoma
William J. H. Davis, M Thompson, Safia M Farry…·Glen Reid
This study identifies MALAT1 as a key lncRNA supporting drug-tolerant persister cells in lung adenocarcinoma, showing its role in treatment resistance and suggesting it as a potential therapeutic target.